Clinical trial Recruiting at 3 sites Phase 2 Interventional Ages 18 and up

Tamsulosin and intraureteral aminophylline to improve ureteral access during primary retrograde intrarenal surgery

Official title: Comparative Efficacy of Tamsulosin, Intraureteral Aminophylline, and Their Combination in Facilitating Ureteral Access During Retrograde Intrarenal Surgery: A Multicenter Randomized Controlled Trial.

Run by Beni-Suef University · NCT07623876 · Data updated 2026-11-12

This trial tests whether taking tamsulosin before surgery, using aminophylline inside the ureter during the operation, or both, helps place the ureteral access sheath on the first try for adults with small unilateral kidney stones undergoing RIRS.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment322 (estimated)
SponsorBeni-Suef University
Academic / other
Locations3 sites (Aswān, Aswan Governorate and 2 other locations)
StatusRecruiting
StartedMay 6, 2026
Main results expectedApril 2027
Study endsMay 2027
Registry record updatedJune 3, 2026
Trial IDNCT07623876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with a unilateral kidney stone 2 cm or smaller planned for primary RIRS requiring a 10/12 Fr ureteral access sheath.

Probably not a fit

Patients without ureteral resistance or spasm, or those not responsive to the studied pharmacologic strategies, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized study uses a 2x2 factorial design to compare preoperative tamsulosin, intraureteral aminophylline, both, or neither in adults with unilateral renal stones ≤2 cm planned for primary retrograde intrarenal surgery. Participants are randomized to one of four groups and receive either active drug or placebo capsules for 7 days before surgery, plus intraureteral aminophylline or placebo during the procedure. The primary outcome is successful first-attempt placement of the planned 10/12 Fr ureteral access sheath without the need for additional maneuvers or abandonment of the procedure. The trial aims to determine whether systemic and/or local pharmacologic strategies reduce ureteral resistance or spasm to facilitate access. This is a prospective, double-blind, placebo-controlled study conducted across multiple centers.

Why it matters

Potential benefit: If successful, the approach could simplify ureteral access during RIRS and reduce the need for additional procedures or delays.

How similar studies have gone: Previous research on alpha-blockers and smooth-muscle relaxants has shown potential to facilitate ureteral access in select cases, but this specific combination and design is being tested in a rigorous multicenter trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Unilateral renal stone 2 cm or less in maximal diameter on preoperative imaging.
* Scheduled for primary retrograde intrarenal surgery.
* Ability to provide written informed consent.

Exclusion Criteria:

* Prior ureteral stenting on the study side.
* Bilateral same-session retrograde intrarenal surgery.
* Concomitant ureteral stone requiring primary semirigid ureteroscopy as the main procedure.
* Known ureteral stricture or prior ureteral reconstructive surgery on the study side.
* Active urinary tract infection or untreated positive urine culture.
* Pregnancy.
* Known allergy or contraindication to tamsulosin or aminophylline.
* Significant cardiac arrhythmia, uncontrolled ischemic heart disease, seizure disorder, or hyperthyroidism.
* Severe hepatic impairment.
* Inability to comply with the 7-day preoperative medication protocol.

Where it's running

  • Department of Urology- Aswan University Hospitals
    Aswān, Aswan Governorate, Egypt
    Recruiting
  • Department of Urology- Beni-Suef University Hospitals
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting
  • Urology Department- Sohag university Hospital
    Sohag, Sohag Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.